CBDS Health Pitch Deck Teardown: A Dual-Track Strategy

Executive Summary: The Bridge Between AgTech and BioTech

The CBDS Health corporate deck, dated December 2018, attempts to solve a common problem in the cannabis industry: the transition from commodity cultivation to high-value pharmaceutical data. The deck is structured around two distinct brands—CBDS Health and GrowBuddy—which represent the research and cultivation arms of the business, respectively. While the presentation provides deep technical and financial projections for both sides, it struggles to present a unified narrative on how these two halves function as a single company.

Slide 1: Title and Branding

The cover slide introduces the dual branding of "CBDS Health Inc." and "GrowBuddy." The tagline for GrowBuddy is "Grow Smarter." The slide is labeled as a "Corporate Deck," suggesting it may be intended for partners or stakeholders rather than being a pure venture capital pitch. The imagery of a cannabis leaf establishes the sector immediately.

Slide 4: Industry Evolution and Margin Strategy

This slide serves as the strategic thesis for the company. It maps the "Evolution of the Cannabis Industry" along an upward-curving arrow. At the bottom left is "Cultivation," labeled as "Low Margins." The arrow moves through "New Product Research & Development" toward "Pharmaceutical" at the top right, which is labeled as "High Margins." This slide clearly communicates that while the company is involved in cultivation, its long-term goal is to capture the higher value associated with pharmaceutical-grade data and products.

Slide 7: Customer Solutions - Cultivation

This is a transition slide marking the beginning of the section focused on GrowBuddy. It uses high-resolution imagery of a cannabis plant to ground the software solution in the physical reality of farming.

Slide 10: GrowBuddy Case Study - DeepRoots Harvest

This slide provides the most compelling evidence for the GrowBuddy software. It highlights a Nevada-based Licensed Producer (LP), DeepRoots Harvest, which has used the software for several years. The metrics cited are specific: a yield increase to 1.3 grams/watt and 94 consecutive successful grows without a failure. The slide includes testimonials from a Cultivation Consultant and a Cultivation Manager, both emphasizing predictability, repeatability, and the ability to refine nutrient schedules based on data. This is a strong "proof of concept" slide that moves beyond theory into realized gains.

Slide 13: The Economics of Yield Improvement

Slide 13 attempts to quantify the value GrowBuddy brings to a commercial operation. It uses an "Annual Plant Capacity Formula" to show that even a 20% minimum yield increase and a 50% crop loss correction result in a 28% increase in value. The table projects annual operating margin increases based on facility size, ranging from $75,600 for a 10,000 sq. ft. facility to $7,560,000 for a 1,000,000 sq. ft. facility. The note at the bottom mentions that historical industry yields are 0.5 grams per watt, contrasting sharply with the 1.3 grams per watt achieved by GrowBuddy users.

Slide 16: Customer Solutions - Research

This transition slide shifts the focus from the farm to the lab. The imagery changes to a medical cross and digital bitstreams (001010), signaling the move into the "High Margin" pharmaceutical and research space mentioned on Slide 4.

Slide 19: The OrcaTech Legacy and IoT Platform

This slide establishes the technical credibility of the CBDS Health platform. It claims the platform has been 15 years in the making , originating from the OrcaTech initiative at Oregon Health Science University (OHSU). The slide lists impressive credentials: 60+ research studies, 1,000+ individuals monitored, over one million hours of data, and 130+ peer-reviewed publications. A "wall of logos" includes massive entities like Intel, Microsoft, Pfizer, and Sony , though these are attributed to the OrcaTech program rather than CBDS Health directly. This slide is intended to show that the company isn't a new startup, but rather a commercialization of a mature, academic-grade IoT platform.

Slide 22: Sleep Study Unit Economics

The final slide in the provided set breaks down the costs for conducting clinical sleep studies using the CBDS Health IoT hub. The pricing is granular, covering hardware (Hub, Sleep Sensor, Pill Box, Vape Pen) and monthly service fees. The total annual cost for a 100-participant study is listed at $207,500 . This slide is critical because it demonstrates a clear B2B revenue model for the research side of the business, moving away from the speculative nature of cultivation yields into fixed-contract research services.

What Works in This Deck

Specific Metrics: The use of "1.3 grams/watt" and "94 consecutive grows" on Slide 10 provides concrete targets that experienced cultivators can validate. This is much more effective than vague claims of "better yields."

Academic Pedigree: Leveraging 15 years of OHSU research (Slide 19) gives the company a level of technical defensibility that most cannabis startups lack. It positions the hardware not as a new gadget, but as a proven medical tool.

Clear Margin Strategy: Slide 4 effectively explains why the company is pursuing two different markets. It acknowledges that cultivation is a race to the bottom (low margins) and justifies the investment in research as a path to higher profitability.

What Is Missing from This Deck

The Team: In the provided slides, there is no mention of the founders, the management team, or the engineers. For a company claiming to bridge OHSU research with commercial cannabis, the lack of biographical data on the people executing this transition is a significant gap.

The Integration Plan: The deck presents GrowBuddy and CBDS Health as two separate entities. It does not explain how data from the GrowBuddy cultivation software feeds into the CBDS Health research platform. Are they two separate businesses, or is there a data flywheel effect?

The Ask: There is no slide detailing how much capital the company is looking to raise, the valuation, or the specific use of funds. Without this, the deck feels more like a sales presentation for partners than a fundraising tool for investors.

Competitive Landscape: The deck assumes a vacuum. There is no mention of other cultivation ERPs (like MJBiz or Seed-to-Sale platforms) or other IoT health monitoring companies. Investors need to know why this specific IoT hub is superior to existing wearables or medical sensors.

Founder's Guide: What to Emulate and What to Avoid

Emulate the Case Study Depth: Slide 10 is a masterclass in using a single client to prove multiple value propositions (yield, reliability, nutrient refinement). If you have one "super-user," dedicate a full slide to their success metrics.

Emulate the Unit Economics: Slide 22 shows exactly what a customer will pay. This removes the guesswork for investors trying to understand the revenue model. Even if the numbers change, showing the structure of your pricing (Setup + Monthly Service) is vital.

Avoid the "Logo Soup" Ambiguity: While the logos on Slide 19 are impressive, they are collaborators of a university program from which the tech originated, not necessarily partners of the startup itself. Founders should be careful to distinguish between their own corporate partnerships and the historical associations of their technology to avoid appearing misleading during due diligence.

Avoid the "Two-Headed Monster" Problem: Running a software company for farmers and a medical data company for researchers are two very different tasks. If your deck covers both, you must spend time explaining how the organization is structured to handle both without losing focus. This deck leaves that question unanswered.